Researchers from the US National Institutes of Health (NIH) and Marengo Therapeutics Inc. previously developed a first-in-class, bifunctional therapeutic molecule (STAR-0602) that selectively ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback